| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
|
Neurology
|
2004
|
5.86
|
|
2
|
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.
|
Neurology
|
2005
|
5.02
|
|
3
|
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.
|
Neurology
|
2009
|
3.72
|
|
4
|
Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications.
|
Neurology
|
2011
|
3.30
|
|
5
|
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.
|
Neurology
|
2007
|
3.24
|
|
6
|
Atrophy rates accelerate in amnestic mild cognitive impairment.
|
Neurology
|
2007
|
2.93
|
|
7
|
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.
|
Neurology
|
2009
|
2.83
|
|
8
|
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.
|
Neurology
|
2008
|
2.69
|
|
9
|
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.
|
Neurology
|
2012
|
2.68
|
|
10
|
1H MR spectroscopy in common dementias.
|
Neurology
|
2004
|
2.39
|
|
11
|
APOE modifies the association between Aβ load and cognition in cognitively normal older adults.
|
Neurology
|
2011
|
2.35
|
|
12
|
Serial MRI and CSF biomarkers in normal aging, MCI, and AD.
|
Neurology
|
2010
|
2.20
|
|
13
|
Diffusion tensor imaging and cognitive function in older adults with no dementia.
|
Neurology
|
2011
|
1.89
|
|
14
|
Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.
|
Neurology
|
2011
|
1.70
|
|
15
|
Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia.
|
Neurology
|
2010
|
1.57
|
|
16
|
Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI.
|
Neurology
|
2010
|
1.45
|
|
17
|
DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment.
|
Neurology
|
2005
|
1.41
|
|
18
|
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
|
Neurology
|
2009
|
1.30
|
|
19
|
Change in MS-related disability in a population-based cohort: a 10-year follow-up study.
|
Neurology
|
2004
|
1.30
|
|
20
|
Disability profile of MS did not change over 10 years in a population-based prevalence cohort.
|
Neurology
|
2004
|
1.16
|
|
21
|
Effects of age on the glucose metabolic changes in mild cognitive impairment.
|
AJNR Am J Neuroradiol
|
2010
|
1.04
|
|
22
|
Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD.
|
Neurology
|
2011
|
0.99
|
|
23
|
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN.
|
Neurology
|
2011
|
0.93
|
|
24
|
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
|
Eur J Neurol
|
2013
|
0.92
|
|
25
|
Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
|
Neurology
|
2012
|
0.82
|
|
26
|
Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
|
Eur J Neurol
|
2015
|
0.80
|